Evidence map›Paper›PMID 32817143›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

First-in-Humans Study of

Riikka Viitanen, Olli Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. [RMD open · 2026
    Article
  5. From incidental positron emission uptake toFrontiers in cardiovascular medicine · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The role of VAP-1 in cardiovascular disease: a review.Frontiers in cardiovascular medicine · 2025
    Review
  11. Article
  12. Article
  13. EXPLORing Arthritis with Total-body Positron Emission Tomography.Seminars in musculoskeletal radiology · 2023
    Review
  14. Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  15. PET/MR imaging of inflammation in atherosclerosis.Nature biomedical engineering · 2023
    Review
  16. Review
  17. [EJNMMI research · 2021
    Article
  18. Article
  19. Radiotracers for Bone Marrow Infection Imaging.Molecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Riikka ViitanenTurku PET Centre, University of Turku, Turku, Finland.
Olli MoisioTurku PET Centre, University of Turku, Turku, Finland.
Petteri LankinenDepartment of Orthopaedics and Traumatology, Turku University Hospital and University of Turku, Turku, Finland.
Xiang-Guo LiTurku PET Centre, University of Turku, Turku, Finland.
Mikko KoivumäkiTurku PET Centre, Turku University Hospital, Turku, Finland.
Sami SuilamoDepartment of Medical Physics, Turku University Hospital, Turku, Finland.
Tuula TolvanenTurku PET Centre, Turku University Hospital, Turku, Finland.
Kirsi TaimenDepartment of Rheumatology and Clinical Immunology, Division of Medicine, Turku University Hospital, Turku, Finland.
Markku MaliDepartment of Rheumatology and Clinical Immunology, Division of Medicine, Turku University Hospital, Turku, Finland.
Ia KohonenDepartment of Radiology, Turku University Hospital, Turku, Finland.
Ilpo KoskivirtaDepartment of Rheumatology and Clinical Immunology, Division of Medicine, Turku University Hospital, Turku, Finland.
Vesa OikonenTurku PET Centre, University of Turku, Turku, Finland.
Helena VirtanenTurku PET Centre, University of Turku, Turku, Finland.
Kristiina SantalahtiMediCity Research Laboratory, University of Turku, Turku, Finland; and.
Anu AutioTurku PET Centre, University of Turku, Turku, Finland.
Antti SarasteTurku PET Centre, University of Turku, Turku, Finland.
Laura PiriläDepartment of Rheumatology and Clinical Immunology, Division of Medicine, Turku University Hospital, Turku, Finland.
Pirjo NuutilaTurku PET Centre, University of Turku, Turku, Finland.
Juhani KnuutiTurku PET Centre, University of Turku, Turku, Finland.
Sirpa JalkanenMediCity Research Laboratory, University of Turku, Turku, Finland; and.
Anne RoivainenTurku PET Centre, University of Turku, Turku, Finland anne.roivainen@utu.fi.
Turku PET Centre · FITurku University Hospital · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sialic acid-binding immunoglubulinlike lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1. A

Indexed as

Positron Emission Tomography Computed TomographyAdultAmine Oxidase (Copper-Containing)Antigens, CDCell Adhesion MoleculesFemaleGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansLigandsMaleRadiopharmaceuticalsSafetySialic Acid Binding Immunoglobulin-like LectinsSolubilityTissue Distribution1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidAmine Oxidase (Copper-Containing)Antigens, CDAOC3 protein, humanCell Adhesion MoleculesGallium-68Gallium RadioisotopesHeterocyclic Compounds, 1-RingLigandsRadiopharmaceuticalsSialic Acid Binding Immunoglobulin-like LectinsSIGLEC9 protein, human68GadosimetrykineticsPETvascular adhesion protein 1whole-body distribution

Identifiers

PMID32817143
PMCPMC8049366
OpenAlexW3065876157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.